Witold O.
- Country
- Poland
- Department
- 40876: Dermatology
Research Overview
- B7981040 - A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBOCONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Ritlecitinib in Adults with Moderate to Severe Hidradenitis Suppurativa
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
Data & Insights
Has run more than one trial at 511 of 852 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating chronic inflammatory skin disorders, with particular emphasis on moderate to severe plaque psoriasis and atopic dermatitis. Their research encompasses both adult and pediatric populations affected by these conditions.
- Plaque Psoriasis Management
- Atopic Dermatitis Therapeutics
- Pediatric Dermatology
Autoimmune Skin Disorders
The investigator focuses on complex autoimmune skin conditions, including cutaneous lupus erythematosus and vitiligo. Their work involves evaluating innovative therapeutic approaches for these challenging conditions.
- Nonsegmental Vitiligo Treatment
- Subacute and Chronic Cutaneous Lupus
- Alopecia Areata Management
Advanced Dermatological Conditions
The investigator studies complex dermatological conditions, with particular attention to hidradenitis suppurativa and acne vulgaris. Their research involves both topical and systemic therapeutic approaches.
- Hidradenitis Suppurativa Treatment
- Acne Vulgaris Management
- Long-term Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.